Biotech & MedTech
-
Dr. Allen Davidoff of XORTX Therapeutics’ on developing therapies for kidney diseases and uplisting to the NASDAQ
In a recent InvestorIntel interview, Chris Thompson spoke with Dr. Allen Davidoff, CEO of XORTX Therapeutics Inc. (NASDAQ:…
-
Sona Nanotech is seeking U.S. FDA approval for its rapid COVID-19 saliva test
Much to my chagrin, it appears this damn COVID virus is refusing to let us be. I guess…
-
The EYES have it, Early Stage Detection of Diabetes and Cardiovascular Disease
Using Artificial Intelligence (AI) to better image and analyze the retina of the eye to detect early stage…
-
Greg Fenton on the significant medical market interest in Zentek’s ZENGuard™ nanotech coatings, plus its new carbon-based icephobic coating
In a recent InvestorIntel interview, Tracy Weslosky spoke with Greg Fenton, CEO and Director of Zentek Ltd. (TSXV: ZEN) about Zentek’s…
-
Revolutionizing the way we treat lack of blood flow diseases by using stem cell therapy
Every year modern medicine makes new breakthroughs that continue to amaze. Today’s company has a breakthrough ‘stem cell…
-
Valeo Pharma’s Redesca™ rollout is progressing rapidly, proving the value of its business model, as its revenue grows 280% in Q3, 2021
Valeo Pharma Inc. (CSE: VPH | OTCQB: VPHIF | FSE: VP2) (“Valeo”) is a specialty pharmaceutical marketing company…
-
Sixth Wave hits the market with MIP coatings and sensors for the biodetection of viruses and bacteria
Sixth Wave Innovations Inc. (CSE: SIXW | OTCQB: SIXWF) (“Sixth Wave”) is a nanotechnology company focused on the…